(+) BioLineRx ( BLRX ), which was surging more than 31% after it said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead oncology candidate, BL-8040 to treat pancreatic cancer.
(+) Evolus ( EOLS ) was climbing by more than 15 following its announcement that the Food and Drug Administration has approved its Jeuveau injectable product for the treatment of frown lines.
(+) Fennec Pharmaceuticals ( FENC ) was up over 8% as it secured a $12.5 million senior debt facility with Bridge Bank.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.